Logotype for Arcus Biosciences Inc

Arcus Biosciences (RCUS) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Arcus Biosciences Inc

Proxy filing summary

21 Apr, 2026

Voting matters and shareholder proposals

  • Election of four directors: Dietmar Berger, David Lacey, Nicole Lambert, and Johanna Mercier, with board recommending a vote for each nominee.

  • Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

  • Advisory approval of named executive officer compensation as disclosed in the proxy statement.

Board of directors and corporate governance

  • Board recommends all director nominees for election at the annual meeting scheduled for June 11, 2026.

Audit committee and external auditor matters

  • Audit Committee has selected Ernst & Young LLP as the external auditor for the upcoming fiscal year, subject to shareholder ratification.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more